Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	230.47	235.64	228.03	253.16	225.11
Revenue Growth (YoY)	-2.19%	3.34%	-9.92%	12.46%	-17.32%
Cost of Revenue	64.4	62.68	55.09	63.7	39.37
Gross Profit	166.06	172.96	172.94	189.45	185.74
Selling, General & Admin	80.16	89.31	89.98	116.29	118.49
Research & Development	54.94	50.38	52.24	71.87	97.65
Operating Expenses	135.1	139.69	142.22	188.16	216.14
Operating Income	30.97	33.27	30.72	1.29	-30.4
Interest Expense	-12.45	-13.33	-11.59	-12.81	-14.05
Interest & Investment Income	4.72	2.61	0.81	0.16	0.49
Other Non Operating Income (Expenses)	0.86	0.76	-0.03	0.29	0.37
EBT Excluding Unusual Items	24.1	23.3	19.91	-11.07	-43.59
Asset Writedown	-	-0.63	-	-	-
Legal Settlements	-	-	-12.46	-9.59	-16.2
Other Unusual Items	-	-	-	-8.15	-
Pretax Income	24.1	22.67	0.46	-28.8	-59.79
Income Tax Expense	-6.18	1.08	0.46	0.32	0.21
Net Income	30.28	21.59	0	-29.13	-60
Net Income to Common	30.28	21.59	0	-29.13	-60
Net Income Growth	40.23%	1079450.00%	-	-	-
Shares Outstanding (Basic)	49	47	45	41	40
Shares Outstanding (Diluted)	49	48	45	41	40
Shares Change (YoY)	3.26%	5.83%	10.56%	2.69%	2.08%
EPS (Basic)	0.62	0.46	0.00	-0.72	-1.52
EPS (Diluted)	0.62	0.45	0.00	-0.72	-1.52
EPS Growth	37.78%	1022625.00%	-	-	-
Free Cash Flow	38.86	26.87	-15.83	20.65	0.73
Free Cash Flow Per Share	0.79	0.56	-0.35	0.51	0.02
Gross Margin	72.06%	73.40%	75.84%	74.84%	82.51%
Operating Margin	13.44%	14.12%	13.47%	0.51%	-13.51%
Profit Margin	13.14%	9.16%	0.00%	-11.51%	-26.65%
Free Cash Flow Margin	16.86%	11.40%	-6.94%	8.16%	0.32%
EBITDA	42.49	44.78	40.56	12.6	-20.37
EBITDA Margin	18.44%	19.01%	17.79%	4.98%	-9.05%
D&A For EBITDA	11.52	11.52	9.84	11.31	10.03
EBIT	30.97	33.27	30.72	1.29	-30.4
EBIT Margin	13.44%	14.12%	13.47%	0.51%	-13.51%
Effective Tax Rate	-	4.78%	99.56%	-	-
Revenue as Reported	230.47	235.64	228.03	253.16	225.11

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q